Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Serotonin 5-HT2A, 5-HT2c and 5-HT1A receptor involvement in the acute effects of psilocybin in mice. In vitro pharmacological profile and modulation of thermoregulation and head-twich response
Authors
Keywords
-
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 154, Issue -, Pages 113612
Publisher
Elsevier BV
Online
2022-08-30
DOI
10.1016/j.biopha.2022.113612
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Increased global integration in the brain after psilocybin therapy for depression
- (2022) Richard E. Daws et al. NATURE MEDICINE
- The promises and perils of psychedelic pharmacology for psychiatry
- (2022) Tristan D. McClure-Begley et al. NATURE REVIEWS DRUG DISCOVERY
- Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects
- (2022) Friederike Holze et al. NEUROPSYCHOPHARMACOLOGY
- The Therapeutic Potential of Psilocybin
- (2021) Henry Lowe et al. MOLECULES
- Trial of Psilocybin versus Escitalopram for Depression
- (2021) Robin Carhart-Harris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Harnessing psilocybin: antidepressant-like behavioral and synaptic actions of psilocybin are independent of 5-HT2R activation in mice
- (2021) Natalie Hesselgrave et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Psilocybin induces rapid and persistent growth of dendritic spines in frontal cortex in vivo
- (2021) Ling-Xiao Shao et al. NEURON
- Prolonged epigenomic and synaptic plasticity alterations following single exposure to a psychedelic in mice
- (2021) Mario de la Fuente Revenga et al. Cell Reports
- 5-HT Receptors and Temperature Homeostasis
- (2021) Irina P. Voronova Biomolecules
- Psychedelics, but Not Ketamine, Produce Persistent Antidepressant-like Effects in a Rodent Experimental System for the Study of Depression
- (2020) Meghan Hibicke et al. ACS Chemical Neuroscience
- Emotions and brain function are altered up to one month after a single high dose of psilocybin
- (2020) Frederick S. Barrett et al. Scientific Reports
- Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species
- (2020) Adam L. Halberstadt et al. NEUROPHARMACOLOGY
- Hallucinogens in Mental Health: Preclinical and Clinical Studies on LSD, Psilocybin, MDMA, and Ketamine
- (2020) Danilo De Gregorio et al. JOURNAL OF NEUROSCIENCE
- A non-hallucinogenic psychedelic analogue with therapeutic potential
- (2020) Lindsay P. Cameron et al. NATURE
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
- (2020) Antonio Inserra et al. PHARMACOLOGICAL REVIEWS
- Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder
- (2020) Alan K. Davis et al. JAMA Psychiatry
- Psychedelic effects of psilocybin correlate with serotonin 2A receptor occupancy and plasma psilocin levels
- (2019) Martin K. Madsen et al. NEUROPSYCHOPHARMACOLOGY
- DARK Classics in Chemical Neuroscience: Psilocybin
- (2018) Haden A. Geiger et al. ACS Chemical Neuroscience
- 5-HT2A receptor agonist-induced hyperthermia is induced via vasoconstriction by peripheral 5-HT2A receptors and brown adipose tissue thermogenesis by peripheral serotonin loss at a high ambient temperature
- (2018) Mami Nakamura et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016
- (2018) James B. Leonard et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The risk factors, frequency and diagnosis of atypical antipsychotic drug-induced hypothermia
- (2018) Anna M. Szota et al. INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY
- Classic Psychedelics: An integrative review of epidemiology, mystical experience, brain network function, and therapeutics
- (2018) Matthew W. Johnson et al. PHARMACOLOGY & THERAPEUTICS
- Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens
- (2016) Anna Rickli et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Long-term follow-up of psilocybin-facilitated smoking cessation
- (2016) Matthew W. Johnson et al. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE
- Potentiation of 5-methoxy-N,N-dimethyltryptamine-induced hyperthermia by harmaline and the involvement of activation of 5-HT1A and 5-HT2A receptors
- (2015) Xi-Ling Jiang et al. NEUROPHARMACOLOGY
- Support for 5-HT2C receptor functional selectivity in vivo utilizing structurally diverse, selective 5-HT2C receptor ligands and the 2,5-dimethoxy-4-iodoamphetamine elicited head-twitch response model
- (2013) Clinton E. Canal et al. NEUROPHARMACOLOGY
- Characterization of the head-twitch response induced by hallucinogens in mice
- (2013) Adam L. Halberstadt et al. PSYCHOPHARMACOLOGY
- Psilocybin Biases Facial Recognition, Goal-Directed Behavior, and Mood State Toward Positive Relative to Negative Emotions Through Different Serotonergic Subreceptors
- (2012) Michael Kometer et al. BIOLOGICAL PSYCHIATRY
- Head-twitch response in rodents induced by the hallucinogen 2,5-dimethoxy-4-iodoamphetamine: a comprehensive history, a re-evaluation of mechanisms, and its utility as a model
- (2012) Clint E. Canal et al. Drug Testing and Analysis
- Spanish regulatory approach for Biobanking
- (2012) Javier Arias-Diaz et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Dysregulated 5-HT2A receptor binding in postmortem frontal cortex of schizophrenic subjects
- (2012) Carolina Muguruza et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens
- (2011) Adam L. Halberstadt et al. NEUROPHARMACOLOGY
- Psilocybin-Induced Deficits in Automatic and Controlled Inhibition are Attenuated by Ketanserin in Healthy Human Volunteers
- (2011) Boris B Quednow et al. NEUROPSYCHOPHARMACOLOGY
- Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects
- (2011) Roland R. Griffiths et al. PSYCHOPHARMACOLOGY
- Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer
- (2010) Charles S. Grob et al. ARCHIVES OF GENERAL PSYCHIATRY
- Functional interactions between 5-HT2A and presynaptic 5-HT1A receptor-based responses in mice genetically deficient in the serotonin 5-HT transporter (SERT)
- (2010) Meredith A Fox et al. BRITISH JOURNAL OF PHARMACOLOGY
- Interaction of 5-HT2A and 5-HT2C Receptors in R(-)-2,5-Dimethoxy-4-iodoamphetamine-Elicited Head Twitch Behavior in Mice
- (2010) W. E. Fantegrossi et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Differential contributions of serotonin receptors to the behavioral effects of indoleamine hallucinogens in mice
- (2010) Adam L Halberstadt et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Enhanced responsivity of 5-HT2A receptors at warm ambient temperatures is responsible for the augmentation of the 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI)-induced hyperthermia
- (2010) Gongliang Zhang et al. NEUROSCIENCE LETTERS
- The serotonin 2C receptor potently modulates the head-twitch response in mice induced by a phenethylamine hallucinogen
- (2010) Clinton E. Canal et al. PSYCHOPHARMACOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started